LEXICON PHARMACEUTICALS, INC. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. for March 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,075 | 0 | 6,225 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,668 | 0 | 5,336 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,339 | 0 | 1,340 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 857 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 16.45 | 2,790 | 45,896 | 20,095 | 22.9 K to 20.1 K (-12.19 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,075 | 0 | 22,885 | 20.8 K to 22.9 K (+9.97 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,668 | 0 | 20,810 | 18.1 K to 20.8 K (+14.71 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,339 | 0 | 18,142 | 16.8 K to 18.1 K (+7.97 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 857 | 0 | 16,803 | 15.9 K to 16.8 K (+5.37 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 4,495 | 0 | 13,485 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 5,807 | 0 | 11,614 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,928 | 0 | 2,929 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,429 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 16.45 | 6,455 | 106,185 | 48,597 | 55.1 K to 48.6 K (-11.73 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 4,495 | 0 | 55,052 | 50.6 K to 55.1 K (+8.89 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 5,807 | 0 | 50,557 | 44.8 K to 50.6 K (+12.98 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,928 | 0 | 44,750 | 41.8 K to 44.8 K (+7.00 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,429 | 0 | 41,822 | 39.4 K to 41.8 K (+6.17 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,352 | 0 | 7,058 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 16.45 | 1,093 | 17,980 | 1,259 | 2.4 K to 1.3 K (-46.47 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,352 | 0 | 2,352 | 0 to 2.4 K |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 4,085 | 0 | 12,255 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 5,271 | 0 | 10,543 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,678 | 0 | 2,679 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,357 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Payment of Exercise | F | 16.45 | 5,361 | 88,188 | 44,230 | 49.6 K to 44.2 K (-10.81 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 4,085 | 0 | 49,591 | 45.5 K to 49.6 K (+8.98 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 5,271 | 0 | 45,506 | 40.2 K to 45.5 K (+13.10 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,678 | 0 | 40,235 | 37.6 K to 40.2 K (+7.13 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,357 | 0 | 37,557 | 35.2 K to 37.6 K (+6.70 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,227 | 0 | 12,683 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,550 | 0 | 9,100 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,822 | 0 | 2,821 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 16.45 | 5,252 | 86,395 | 24,613 | 29.9 K to 24.6 K (-17.59 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,227 | 0 | 29,865 | 25.6 K to 29.9 K (+16.49 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,550 | 0 | 25,638 | 21.1 K to 25.6 K (+21.58 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,822 | 0 | 21,088 | 18.3 K to 21.1 K (+15.45 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,500 | 0 | 18,266 | 15.8 K to 18.3 K (+15.86 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 8,390 | 0 | 25,170 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 10,836 | 0 | 21,671 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 16.45 | 5,258 | 86,494 | 20,767 | 26 K to 20.8 K (-20.20 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 8,390 | 0 | 26,025 | 17.6 K to 26 K (+47.58 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 10,836 | 0 | 17,635 | 6.8 K to 17.6 K (+159.38 %) |